학술논문

Survival in patients diagnosed with SMA at less than 24 months of age in a population-based setting before, during and after introduction of nusinersen therapy. Experience from Sweden
Document Type
Article
Source
In: European Journal of Paediatric Neurology. (European Journal of Paediatric Neurology, September 2022, 40:57-60)
Subject
Language
English
ISSN
15322130
10903798